HOME >> MEDICINE >> NEWS
"Powerful New Tool" For AIDS Is Reported In Science

Approach permits targeted, patient- specific treatment, optimization of existing drug therapies (cocktails) and accelerated new drug discovery

State College, PA-- February 25, 1998 -- Science reported, in its 20 February 1998 issue, a novel AIDS directed technology developed by Dr. Marc Hellerstein of the University of California at Berkeley and the University of California at San Francisco.

The technology will be commercialized exclusively by SpectruMedix Corporation (OTC: SMDX), of State College, PA., which is playing a crucial ongoing role in developing the required instrumentation. Initial in vivo results of T cell proliferation rates in AIDS patients using isotope mass spectrometric techniques were announced Feb. 3, 1998 at the 5th Conference on Retroviruses and Opportunistic Infections. The results are part of an ongoing collaboration designed to change the diagnosis and management of AIDS and to optimize its therapeutic approach by allowing physicians to rapidly measure the efficacy of a drug or treatment modality in an individual patient. This diagnostic technique may finally allow physicians to establish, based upon objective evidence, the proper time for an individual AIDS patient to begin taking medication and which medication is best suited for this particular individual. (A description of this new technique was published in the 20 January 1998 issue of The Proceedings of The National Academy of Sciences: 'Measurement of Cell Proliferation etc.')

Science reported that researchers have long sought such a technique to help reveal the intricacies of the battle between the immune system and HIV. Dr. David Ho, head of the Aaron Diamond AIDS Research Center in New York City is quoted in the article in Science as saying "I think they've made a genuine contribution to the field".

The results of this study indicate that the body's capacity to make new cells was in fact the key determinant of T cell counts and the pat
'"/>

Contact: Bernard Sonnenschein
bernard@spectrumedix.com
814-867-8600
SpectruMedix Corporation
25-Feb-1998


Page: 1 2 3 4

Related medicine news :

1. Intestine Transplant Results Reported At American Society Of Transplantation Meeting
2. Compound That Mimics Insulin Might Lead To Pill For Diabetes, As Reported In The 7 May Issue Of Science
3. Insulin Resistance And Obesity Avoided In Genetically Modified Mice, As Reported In Science
4. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine
5. Adverse Drug Reactions Are Under Reported
6. National Academies advisory: May 2 Symposium on International Science Policy
7. 2005 Behavioral Sciences & Health Services Research Award
8. Innovation prize finalists announced in Science of Better
9. NIH panel issues State-of-the-Science statement on end-of-life care
10. 2004 Science-in-Society Award winners announced
11. Dec. 10-12 Japanese-American Frontiers of Science Meeting in Irvine, Calif.

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Powerful New Tool For AIDS Reported Science

(Date:6/18/2013)... Internationally acclaimed plastic surgeon, Dr. ... showcasing his unique approach to breast augmentation. Dr. ... surgical method and highlights the results of Dr. ... Dr. Tebbetts compares his breast augmentation method to ... method does not necessitate the use drains, bandages, ...
(Date:6/18/2013)... cancer cells have a much different and more ... The University of Texas at Dallas have found that ... combat lung cancer. , In an article published online ... UT Dallas researchers compared the metabolic characteristics of non-small-cell ... the same patient. , They found that the ...
(Date:6/18/2013)... clinical researchers have launched an innovative clinical trial, ... ability of a patient,s own stem cells to ... disease (PAD). , Led by Vik Kashyap, ... Case Medical Center,s Harrington Heart & Vascular Institute ... University School of Medicine, the clinical trial is ...
(Date:6/18/2013)... venture, using technology developed at Case Western Reserve ... School of Engineering, has made available avatarsvirtual patientsto ... students and others training to evaluate speech-language disorders ... stress on the trainee, because a diagnosis doesn,t ... , Graduate students studying to become speech-language ...
(Date:6/18/2013)... Researchers have discovered and mapped the signaling network ... if broken, could cut off cancer cell growth at ... at The University of Texas MD Anderson Cancer Center ... a well-known cancer drug target, and MCM7, a protein ... the June issue of Cancer Cell . , ...
Breaking Medicine News(10 mins):Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:SimuCase avatars advance speech-language pathology training 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/17/2013)... 17, 2013 Velplex, LLC announced this week ... platform that connects buyers and sellers of discount ... leader. Why? It,s because the business ... familiar with the dental industry. They have 50 years ... diligently worked to negotiate some of the best prices ...
(Date:6/17/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... a preliminary prospectus supplement to its effective shelf registration statement ... with securities regulatory authorities in each of the provinces of ... offering of its common shares to raise gross proceeds of ... also grant to the underwriters of the Offering an option, ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
Cached News: